New combo therapy aims to beat back leukemia after transplant failure
Disease control
Recruiting now
This study tests a combination of interferon-γ and donor immune cells for adults whose acute myeloid leukemia or myelodysplastic syndromes have returned after a stem cell transplant. The goal is to see if this treatment can control the disease and improve survival. About 45 parti…
Phase: PHASE2 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated May 26, 2026 08:33 UTC